Question· QUESTION_WRITTENE-9-2021-002599answered
Information du consommateur sur la présence d’ingrédients, d’additifs et de résidus de pesticides dans les boissons alcoolisées
European Union · European Parliament · 12 May 2021
Person
Michèle RIVASI
European Union · Official source
Records
182 records where Michèle RIVASI is listed as a sponsor, author, or other actor. Search with topics and years
Question· QUESTION_WRITTENE-9-2021-002598answered
Pesticide residue from veterinary medicine and the new Transparency Regulation
European Union · European Parliament · 12 May 2021
Question· QUESTION_WRITTENE-9-2021-002283answered
Erdbebenrisiko in Bezug auf das AKW Paks II
European Union · European Parliament · 28 April 2021
Question· QUESTION_WRITTENE-9-2021-001810answered
Seuil maximal de cycles d’amplification recommandé par l’ECDC pour les tests RT-PCR détectant le SARS-CoV-2
European Union · European Parliament · 1 April 2021
Question· QUESTION_WRITTENE-9-2021-001806answered
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
European Union · European Parliament · 1 April 2021
Question· QUESTION_WRITTENE-9-2021-001751answered
AstraZeneca vaccine production and black market in vaccines
European Union · European Parliament · 30 March 2021
Question· QUESTION_WRITTENE-9-2021-001688answered
The contribution of the International Thermonuclear Experimental Reactor (ITER) project to climate action
European Union · European Parliament · 25 March 2021
Question· QUESTION_WRITTENE-9-2021-001008answered
Fehlende Pflicht zur Kennzeichnung technischer Enzyme in der Lebensmittelverarbeitung
European Union · European Parliament · 19 February 2021
Question· QUESTION_WRITTENE-9-2021-000135answered
Bias in EFSA’s toxicological assessment of aspartame
European Union · European Parliament · 12 January 2021
Question· QUESTION_WRITTENE-9-2020-007050answered
Grenzüberschreitendes UVP-Verfahren zu Laufzeitverlängerungen von Reaktoren in der EU
European Union · European Parliament · 23 December 2020
Question· QUESTION_WRITTENE-9-2020-006993answered
Decision of the European Ombudsman regarding the Commission’s decision to award a contract to BlackRock for a study on integrating environmental, social and governance (ESG) objectives into EU banking rules
European Union · European Parliament · 18 December 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-006641open
Transparency of contracts for COVID-19 vaccines
European Union · European Parliament · 4 December 2020
Question· QUESTION_WRITTENE-9-2020-006318answered
Criteria and minimum efficacy levels for evaluating COVID-19 vaccines
European Union · European Parliament · 19 November 2020
Question· QUESTION_WRITTENE-9-2020-006170answered
Lack of human resources at the EMA for the rapid evaluation of COVID-19 vaccines and therapeutics
European Union · European Parliament · 12 November 2020
Question· QUESTION_WRITTENE-9-2020-006016answered
Respect des directives «Natura 2000» par la France
European Union · European Parliament · 4 November 2020
Question· QUESTION_WRITTENE-9-2020-006001answered
Health issues of people living next to large-scale animal farms
European Union · European Parliament · 4 November 2020
Question· QUESTION_WRITTENE-9-2020-005767answered
Efficacy of remdesivir and transparency with regard to the conditions of the recent Joint Procurement Agreement
European Union · European Parliament · 23 October 2020
Question· QUESTION_WRITTENE-9-2020-005595answered
Support for the proposed waiver on some sections of the Agreement on Trade-Related Aspects of Intellectual Property Rights to facilitate the prevention, containment and treatment of COVID‑19
European Union · European Parliament · 13 October 2020
Question· QUESTION_WRITTENE-9-2020-005554answered
Energy Charter Treaty renegotiation: the EU’s position regarding fossil fuels protection, the Investor-State Dispute Settlement mechanism and public information
European Union · European Parliament · 12 October 2020
Question· QUESTION_WRITTENE-9-2020-005517answered
Prosecution of NGOs in Greece
European Union · European Parliament · 7 October 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-005248open
Positions de l’EMA et de la Commission sur le placebo non conforme dans les essais cliniques du vaccin Covid19 d’AstraZeneca
European Union · European Parliament · 25 September 2020
Question· QUESTION_WRITTENE-9-2020-005245answered
5G and health risk of EMF: Commission is deliberately confusing SCENIHR and SCHEER opinions
European Union · European Parliament · 24 September 2020
Question· QUESTION_WRITTENE-9-2020-005239answered
CETA et boeuf aux hormones: des «défaillances» dans le contrôle des importations de boeuf canadien vers l’Europe
European Union · European Parliament · 24 September 2020
Question· QUESTION_WRITTENE-9-2020-004735answered
Mass arrest of LGBTI activists in Poland
European Union · European Parliament · 1 September 2020
Question· QUESTION_ORALO-9-2020-000051open
Imminent threat to the rule of law and democracy in Bulgaria
European Union · European Parliament · 14 August 2020
Question· QUESTION_WRITTENE-9-2020-004498answered
L’avenir de l’instrument relatif à la coopération en matière de sûreté nucléaire
European Union · European Parliament · 4 August 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-003908open
Éthique et sécurité des vaccins OGM et non OGM contre la COVID-19
European Union · European Parliament · 1 July 2020
Question· QUESTION_WRITTENE-9-2020-003810answered
Transparence des données cliniques pour la stratégie européenne en matière de vaccins contre la COVID-19
European Union · European Parliament · 29 June 2020
Question· QUESTION_WRITTENE-9-2020-003754answered
Budget allocation for development projects in Eritrea
European Union · European Parliament · 24 June 2020
Question· QUESTION_WRITTENE-9-2020-003753answered
Internal procurement for Eritrea road project
European Union · European Parliament · 24 June 2020
Question· QUESTION_WRITTENE-9-2020-003672answered
Green Deal compatibility criteria for Projects of Common Interest
European Union · European Parliament · 18 June 2020
Question· QUESTION_WRITTENE-9-2020-003612answered
Stratégie de l’Union en faveur de la biodiversité à l’horizon 2030 et protection des peuples autochtones
European Union · European Parliament · 16 June 2020
Question· QUESTION_WRITTENE-9-2020-003564answered
Fonds mondial pour la nature et protection des peuples autochtones
European Union · European Parliament · 15 June 2020
Question· QUESTION_WRITTENE-9-2020-003450answered
Fraude alimentaire, mauvais étiquetage et modification des produits alimentaires dans l’Union européenne
European Union · European Parliament · 10 June 2020
Question· QUESTION_WRITTENE-9-2020-003419answered
Farm to Fork Strategy: exclusion of meat and dairy-related measures from the final roadmap
European Union · European Parliament · 8 June 2020
Question· QUESTION_ORALO-9-2020-000041open
Strategic approach to pharmaceuticals in the environment
European Union · European Parliament · 4 June 2020
Question· QUESTION_ORALO-9-2020-000040open
Strategic approach to pharmaceuticals in the environment
European Union · European Parliament · 4 June 2020
Question· QUESTION_WRITTENE-9-2020-003257answered
Invasion de criquets pèlerins en Afrique de l’Est et COVID-19
European Union · European Parliament · 28 May 2020
Question· QUESTION_WRITTENE-9-2020-003161answered
Interdiction de la publicité ciblant les enfants et les jeunes
European Union · European Parliament · 25 May 2020
Question· QUESTION_WRITTENE-9-2020-003030answered
Tabac — Stratégie d’influence des cigarettiers et financement de la vie politique en Europe
European Union · European Parliament · 15 May 2020
Question· QUESTION_WRITTENE-9-2020-002843answered
Risk assessment and infection prevention measures for children and in educational institutions
European Union · European Parliament · 7 May 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-002498open
5G, the virus and the immune-repressing effect of long-term exposure to radio frequency electromagnetic waves
European Union · European Parliament · 24 April 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-001530open
Conformité du système de traçabilité des produits du tabac en vigueur dans l’Union avec les obligations de la convention-cadre de l’OMS pour la lutte antitabac
European Union · European Parliament · 11 March 2020
Question· QUESTION_ORALO-9-2020-000026open
Strategic approach to pharmaceuticals in the environment
European Union · European Parliament · 6 March 2020
Question· QUESTION_ORALO-9-2020-000025open
Strategic approach to pharmaceuticals in the environment
European Union · European Parliament · 6 March 2020
Question· QUESTION_ORALO-9-2020-000018open
Facial recognition and identification in publicly accessible spaces
European Union · European Parliament · 1 March 2020
Question· QUESTION_WRITTENE-9-2020-000373answered
Fukushima — rejet envisagé de l’eau contaminée dans l’océan
European Union · European Parliament · 23 January 2020
Record· QUESTION_WRITTEN_PRIORITYP-9-2020-000221open
5G, Commission internationale de protection contre les rayonnements non ionisants (ICNIRP) et indépendance du Comité scientifique des risques sanitaires émergents et nouveaux (CSRSEN)
European Union · European Parliament · 15 January 2020
Question· QUESTION_WRITTENE-9-2019-004590answered
Making the Nutri-Score food label mandatory: a public health issue
European Union · European Parliament · 20 December 2019
Record· QUESTION_WRITTEN_PRIORITYP-9-2019-003802open
Règlement (UE) 2017/745 sur les dispositifs médicaux et pénurie d’organismes notifiés en 2020
European Union · European Parliament · 13 November 2019